Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5)

Condition:   Meningococcal Meningitis Interventions:   Biological: NmCV-5;   Biological: Menactra Sponsors:   Serum Institute of India Pvt. Ltd.;   PATH Not yet recruiting

Source: ClinicalTrials.gov - May 27, 2019 Category: Research Source Type: clinical trials